S4 Induces Apoptosis, Cell Cycle Arrest, and Metabolic Alterations in Breast Cancer Cells.
The findings suggest that S4 treatment is associated with significant alterations in breast cancer growth and metabolic pathways, and suggests that S4 exploits unique metabolic vulnerabilities, supporting further investigation of SARMs in breast cancer models.